Provided by Tiger Trade Technology Pte. Ltd.

Repligen

181.13
+0.84000.47%
Post-market: 181.00-0.1300-0.07%19:30 EDT
Volume:1.10M
Turnover:198.19M
Market Cap:10.20B
PE:248.12
High:182.43
Open:179.66
Low:175.75
Close:180.29
52wk High:188.73
52wk Low:100.99
Shares:56.29M
Float Shares:53.32M
Volume Ratio:1.05
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:4.83
PE(LYR):210.62

Loading ...

Ashland Q3 Profit Beats on Higher Volume, Pricing; Cuts FY EPS Forecast

Reuters
·
Jul 29

Repligen rises 15.4%

TIPRANKS
·
Jul 29

Repligen up over 15%, on Pace for Largest Percent Increase Since July 2024

Dow Jones
·
Jul 28

Movement Alert|Repligen Rises 15.35% in Regular Trading, Q2 Earnings Significantly Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Jul 28

Repligen Earns Buy Rating on Strong Q2 Beat, Raised Guidance, and Broad-Based Demand Strength

TIPRANKS
·
Jul 28

Repligen Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 28

Stock Track | Repligen Soars 6.59% in pre-market on Strong Q2 Earnings Beat and Raised Full-Year Guidance

Stock Track
·
Jul 28

Nautilus Biotechnology Posts First Revenue, Q2 Net Loss Narrows

Reuters
·
Jul 28

Repligen Q2 Revenue Beats Estimates on Higher Orders; Raises Outlook

Reuters
·
Jul 28

Repligen Q2 GAAP EPS Drops 65.38% to $0.09; Revenue Rises 12% to $204 Million

Reuters
·
Jul 28

GUIDANCE: (RGEN) Repligen Expects 2026 Adjusted EPS Range $2.03-$2.09, vs. FactSet Est of $2.00

MT Newswires Live
·
Jul 28

Repligen Q2 Adj. EPS $0.54 Beats $0.45 Estimate, Sales $204.128M Beat $201.483M Estimate

Benzinga Earnings
·
Jul 28

Repligen Q2 Adjusted EPS USD 0.54 Vs. IBES Estimate USD 0.45

Reuters
·
Jul 28

Repligen Outlook FY Revenue USD 813-835 Million

THOMSON REUTERS
·
Jul 28

Repligen Outlook FY Adjusted EPS USD 2.03-2.09

THOMSON REUTERS
·
Jul 28

RBC Capital Remains a Buy on Repligen (RGEN)

TIPRANKS
·
Jul 24

Analysts Offer Insights on Healthcare Companies: Community Health (CYH), AnaptysBio (ANAB) and Repligen (RGEN)

TIPRANKS
·
Jul 23

France's Sartorius Stedim Biotech H1 Revenue Rises on Recurring Consumables

Reuters
·
Jul 23

Biolife Solutions Co May be Required to Pay Repligen Termination Fee of $59 Million, if Deal Terminates Under Certain Circumstances- SEC Filing

Reuters
·
Jul 23

Medpace Q2 Revenue Beats Estimates on Backlog Conversion

Reuters
·
Jul 23